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Introduction:  The  objectives  of  this  study  were  to evaluate  whether  healthcare  infrastruc-
ture impacts  delay  in  diagnosis,  and  to  determine  whether  healthcare  infrastructure  and
delay  in diagnosis  impacts  survival  in  gastric  cancer.
Methods:  Administrative  data  from  2175  gastric  cancer  patients  was  analyzed  using  two
Cox proportional  hazard  models  with  (i) delay  in  diagnosis  and  (ii)  survival  as  dependent
variables.  Density  of  general  practitioners,  density  of  gastroenterologists,  characteristics  of
specialty  treatment  centers,  demographic  information,  and  comorbidities  were  included  in
the  models.  Differentiation  was  made  between  urban  and  rural  areas.
Results:  The  likelihood  of  being  diagnosed  increased  with  an  increase  in  general  practi-
tioners  (p <  0.0001)  and  gastroenterologists  (p  < 0.0001)  in  rural  areas.  In urban  areas  a
higher  density  of  general  practitioners  reduced  delay  in  diagnosis  (p = 0.0262),  while  a
higher density  of gastroenterologists  did  not  (p =  0.2480).  The  number  of gastric  cancer
cases performed  in  hospital  had  a positive  impact  on  survival  (p <  0.0001),  while  outpatient
infrastructure  did  not.
Conclusion:  Delay  in  diagnosis  can  be  reduced  by  higher  availability  of general  practitioners
and  gastroenterologists  in  rural  areas.  Given  the  already  very  high  density  of  physicians
in  urban  areas  there  is  no  effect  of  additional  gastroenterologists.  As  learning  effects  can
be observed  with  increased  hospital  volumes,  minimum  volumes  for  treatment  of gastric
cancer may  be deﬁned.
© 2012 Elsevier Ireland Ltd. Open access under CC BY-NC-ND license. . Introduction
The efﬁcient allocation of healthcare resources in
ealthcare infrastructure is one of the most challenging
uestions in health policy. Availability of healthcare infras-
ructure – deﬁned as density of physicians, distances to
pecialty treatment centers, and specialization of hospi-
als – is clearly a prerequisite for the use of healthcare
esources; the problem for decision makers, however, is
∗ Correspondence address: Hamburg Center for Health Economics, Uni-
ersity of Hamburg, Esplanade 36, D-20354 Hamburg, Germany.
el.: +49 40 42838 4677; fax: +49 40 42838 8043.
E-mail address: rudolf.blankart@wiso.uni-hamburg.de
168-8510 © 2012 Elsevier Ireland Ltd. 
oi:10.1016/j.healthpol.2012.01.006
Open access under CC BY-NC-ND license. to determine if an investment in more healthcare infras-
tructure will result in better outcomes. Within this context,
gastric cancer is used as an example because it is a rare dis-
ease which often results in delayed diagnosis. Rare diseases
such as gastric cancer may  beneﬁt from a richer healthcare
infrastructure in two ways: earlier diagnosis and better
treatment.
Although incidence of gastric cancer is high, current
prevalence-based deﬁnitions classify it as a rare disease
with a prevalence of 20 per 100,000 [1].  There are, how-
ever, large differences between continents. The highest
incidence can be found in northeast Asia (69 cases per
100,000 people per year), while Europe has an intermediate
rate, and there are low incidence rates in North Amer-
ica, Africa, South Asia, and Oceania with about 4–10 cases
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Classiﬁcation of Procedures in Medicine). Inpatient care
data includes date of admission, hospital location (ﬁve-
digit postcode), diagnoses, and procedures performed.C.R. Blankart / Health
per 100,000 people [2].  In Germany, gastric cancer is the
eighth most common – though still rare – cancer site for
women and the ﬁfth most common cancer site for men  [3].
Both incidence and mortality for gastric cancer have been
decreasing steadily in all developed countries for about
thirty years. In Germany, the annual age-standardized mor-
tality rate per 100,000 decreased from 25.3 to 7.4 for males
(13.0–3.9 for females) between 1976 and 2006 [4].
Gastric cancer is difﬁcult to diagnose in its early stages,
because it often progresses asymptomatically or causes
only nonspeciﬁc symptoms. In addition, physicians tend
to misinterpret symptoms and treat the patient for acid
reﬂux disease. However, the longer the disease goes undi-
agnosed, the more advanced the tumor stage becomes and
the poorer the prognosis [5,6]. The primary choice in treat-
ment of gastric cancer is gastric resection of the primary
tumor and regional lymph nodes. Surgery may  only be
performed if the tumor is local and not metastasized. In
some cases, neo-adjuvant chemo- and/or radiotherapy is
performed to reduce the tumor to an operable size before
surgery. Adjuvant chemo- and/or radiotherapy may  also
be applied to slow progression of the disease. In late stages
of the disease, treatment of gastric cancer is palliative or
symptomatic only [5,7].
Current literature evaluates delay in diagnosis accord-
ing to patient-speciﬁc factors such as sex, age, socio-
economic status, or comorbidities. However, none of the
nineteen studies reported in a comprehensive review of
delay in diagnosis by Macdonald et al. evaluated the
impact of healthcare infrastructure [8].  The available
literature on healthcare infrastructure focuses on the rela-
tionship between healthcare infrastructure and utilization
of healthcare services and healthcare consumption [9,10].
Unlike the relationship between inpatient health-
care infrastructure and outcomes, which has been well
researched, the impact of outpatient healthcare infrastruc-
ture on survival after diagnosis of gastric cancer seems to be
under-researched. Enzinger et al. ﬁnd that hospital volume
has no effect on overall survival [11], whereas Birkmeyer
et al. state that there is a signiﬁcant positive relationship
between hospital volume and survival after gastric can-
cer surgery [12]. Nomura et al. ﬁnd a signiﬁcant negative
relationship between mortality and hospital volume for
hospitals with a very low volume [13]. None of the above-
mentioned studies controlled for availability of outpatient
healthcare infrastructure at the patient’s location.
The objective of this study is to evaluate the impact of
healthcare infrastructure in gastric cancer treatment using
administrative data from a large German sickness fund.
This study examines two research hypotheses. The ﬁrst
concerns the effect of healthcare infrastructure on delay
in diagnosis: Model I tests the hypothesis that improved
healthcare infrastructure at the patient’s location reduces
delay in diagnosis. The second concerns the impact on sur-
vival of healthcare infrastructure and delay in diagnosis:
model II tests the hypothesis that improved healthcare
infrastructure and shorter delay in diagnosis has a positive
impact on survival.
The paper is organized as follows. Section 2 presents the
data used, the study setting, and describes the methodolog-
ical framework to estimate delay in diagnosis and survival.05 (2012) 128– 137 129
Section 3 shows the results and in Section 4 the ﬁndings
are discussed with evidence from existing literature. The
ﬁnal section summarizes the results and gives recommen-
dations for policy implications.
2. Material and methods
2.1. Data and study setting
The study uses data provided by Techniker
Krankenkasse, a large German sickness fund that cov-
ers about 7.6 million people, i.e., about 9% of Germany’s
population. The dataset includes all persons insured by
the fund who  had at least one diagnosis of gastric cancer
between January 2004 and September 2009. Patients are
considered as initially diagnosed if they had their (a) initial
and (b) reliable ICD10-GM (a German modiﬁcation of the
ICD10) diagnosis of gastric cancer (C16) within the period
under observation [14]. Patients have been considered as
initially diagnosed if they have not been diagnosed with
gastric cancer during two year of time before their poten-
tial initial diagnosis. Patients that have not been insured
during two years before their potential initial diagnosis
– and therefore have not been under observation – have
been excluded because it could not be ensured that the
diagnosis found was their true initial diagnosis. Inpatient
diagnosis codes are considered reliable because they are
relevant for reimbursement purposes and therefore of
a high reporting quality. However, outpatient diagnosis
codes are considered as reliable only where they have
been coded repeatedly within 180 days.
Patients who were diagnosed with malignant neo-
plasms of digestive organs (ICD10-GM C15-C26) before
the initial diagnosis of gastric cancer have been excluded,
because it can be assumed that the gastric cancer is a
metastasis and not a primary cancer site. In addition, all
patients who relocated during the period under obser-
vation have been removed, in order to ensure consistent
analysis of healthcare infrastructure. Relocation of a patient
was assumed to have occurred if a patient received out-
patient diagnoses in more than one main postcode region
(Germany is divided into nine main postcode regions) in
two consecutive quarters of a year [14]. Finally, patients
for whom information was missing that had to be included
in the regression model have been excluded.
The dataset includes information on age, sex, the
patient’s place of residence as a three-digit postcode,1
outpatient and inpatient care received, and data on the
consumption of pharmaceuticals. Outpatient care data
includes consultation dates, location of the physician as
a three-digit postcode, and diagnoses coded with ICD10-
GM codes as well as surgeries and procedures coded with
OPS301 codes (a German modiﬁcation of the International1 Germany is subdivided into about 700 different 3-digit and 27,000
5-digit post code areas. A 3-digit post code covers, on average, an area of
500 km2, and a 5-digit post code an area of 13 km2.
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days was deﬁned as the dependent variable and death
as the event. In addition, a predicted survival curve for
patients with gastric cancer was plotted.30 C.R. Blankart / Health
Data on the number of physicians in 2008 was retrieved
rom the National Association of SHI Accredited Physicians,
hile data on Germany’s population and geography was
etrieved from the Federal Statistical Ofﬁce in Germany
15]. Information on travel distances was retrieved from
oogle Maps. It has been assumed that the patient travels
y car, following the ﬁrst of Google Maps’ suggested routes
16]. Hospital data on gastrointestinal surgeries and nurs-
ng staff was obtained from the national hospital quality
ecords 2008 [17].
.2. Model I: impact of healthcare infrastructure on delay
n diagnosis
A Cox proportional hazard model with delay in diagno-
is as the dependent variable was employed to evaluate the
elationship between healthcare infrastructure and delay
n diagnosis (model I). Delay in diagnosis in days was mea-
ured between the onset of the disease (ﬁrst symptoms)
nd initial diagnosis. Initial diagnosis of gastric cancer was
eﬁned as the event. In addition, a predictive survival curve
or patients diagnosed with gastric cancer was plotted.
To determine the onset of the disease, gastric can-
er has been assumed to be prevalent but undiagnosed
f gastric-cancer-related symptoms were present within a
wo-year period before the initial diagnosis [14]. Patients
hat showed ﬁrst symptoms in the ﬁrst 180 days of the
wo-year period have been excluded to ensure that symp-
oms were not present in the time before the two-year
eriod. Symptoms were derived from clinical literature
n gastric cancer [7,18–20]. Presence of a symptom was
ssumed if the patient was diagnosed with one of the fol-
owing symptoms before initial diagnosis: D13.1, benign
eoplasm of other and ill-deﬁned parts of digestive sys-
em (stomach); D37.1, neoplasm of uncertain or unknown
ehavior of oral cavity and digestive organs (stomach);
20, oesophagitis; Z12.0, special screening examination for
eoplasm of stomach; K21, gastro-oesophageal reﬂux dis-
ase; K25, gastric ulcer; K26, duodenal ulcer; K27, peptic
lcer, site unspeciﬁed; K29, gastritis and duodenitis; K30,
yspepsia; K92, other diseases of digestive system; K31,
ther diseases of stomach and duodenum; K59, other func-
ional intestinal disorders; R07, pain in throat and chest;
10, abdominal and pelvic pain; R11, nausea and vomit-
ng; R12, heartburn; R13, dysphagia; R14, ﬂatulence and
elated conditions; R16, hepatomegaly and splenomegaly,
ot elsewhere classiﬁed; R19, other symptoms and signs
nvolving the digestive system and abdomen; R53, malaise
nd fatigue; R63.0, symptoms and signs concerning food
nd ﬂuid intake: anorexia; and R63.4, symptoms and signs
oncerning food and ﬂuid intake: abnormal weight loss.
here there were no symptoms within the two  years prior
o gastric cancer diagnosis, it has been assumed that the
atient was diagnosed immediately (delay in diagnosis = 0
ays).
Outpatient healthcare infrastructure was deﬁned as
ensity of general practitioners and density of gastroen-
erologists per 100 square kilometers in a three-digit
ostcode area in order to measure the effect of availability
f physicians. Full-time equivalents were used for calcula-
ion of outpatient physician density and a differentiation05 (2012) 128– 137
was  made between urban and rural areas. Inpatient
healthcare infrastructure was  deﬁned by travel distances
between the patient’s three-digit postcode and location
of a specialty treatment center for gastric cancer. Travel
distances between the three-digit postcode of the patient2
and location of the closest specialty treatment center were
calculated using Google Maps. Hospitals were considered
as specialty treatment centers if the hospital belonged to
the top 10% of hospitals according to the number of gastric
cancer cases in 2008.
In addition to sex as a time-independent variable, the
model controls for sex as a time-dependent control variable
due to a violation of the proportional hazard assumption.
The time-dependent variable was deﬁned as 1 if the sex
was  female and the delay in diagnosis was lower than 270
days; otherwise the variable was deﬁned as 0. Age classes
were determined at time of diagnosis and divided as fol-
lows: 60 years or younger, 60–69 years, 70–79 years, and
80 years or older. The number of consultations within 180
days before occurrence of gastric cancer symptoms has
been included as a proxy for the patient’s propensity to visit
a physician.
Comorbidities that appeared within 180 days before
the ﬁrst symptom have been included. Comorbidities were
measured using the Elixhauser comorbidity groups [21,22]
as valid prognostic indicators for administrative ICD-10
data in predicting short- and long-term mortality [23] in
both models. Comorbidities were counted by using all in-
and outpatient diagnoses rendered to patients within the
180 days period.
Due to multicollinearity issues between density of
general practitioners and density of gastroenterologists
(Pearson’s correlation coefﬁcient = 0.847), the model has
been estimated twice: the ﬁrst estimation addresses the
impact of general practitioners (model Ia), and the second
the impact of gastroenterologists (model Ib).
2.3. Model II: impact of healthcare infrastructure on
survival
To evaluate the relationship between healthcare infras-
tructure and survival (model II), all patients who were not
treated with inpatient surgery, radio- or chemotherapy
have been excluded, because explanatory hospital vari-
ables are included in the model, e.g., number of gastric
cancer cases. A patient was  considered to have had gas-
tric surgery if the patient had an inpatient stay and if
an incision, excision, resection, or other surgery on the
stomach (OPS301 code 5-43 and 5-44) was  performed.
Radio- and chemotherapy was identiﬁed by screening in-
and outpatient data for radiotherapy (OPS301 8-52) and
chemotherapy procedure codes (OPS301 8-53). A Cox pro-
portional hazard model was  employed, where survival in2 It has been assumed that the patient’s place of residence is always
in the middle of the ﬁrst valid 5-digit postcode following the – with ‘00’
extended – 3-digit postcode.
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Outpatient healthcare infrastructure was measured
as density of general practitioners and density of gas-
troenterologists. Inpatient healthcare infrastructure was
dependent on the place of treatment. Place of treatment
was primarily determined by (a) the hospital where the
patient ﬁrst obtained surgery, or (b) the hospital where the
patient ﬁrst obtained radio- or chemotherapy. The number
of gastric cancer cases performed and intensity of nursing
care have been added in order to measure inpatient health-
care infrastructure. Intensity of nursing care was deﬁned by
the number of nursing staff per hospital bed. In addition,
delay in diagnosis was included to measure the effect on
survival.
Inpatient surgery, as well as out- and inpatient radio-
and chemotherapy, were deﬁned as time-dependent con-
trol variables to take account of the fact that the chance of
receiving one of these therapies is lower for patients dying
early. The variables are deﬁned as 0 before the performance
of the procedure and 1 thereafter. Sex and age, divided into
classes, were deﬁned as further control variables. Similar to
model I, comorbidities that appeared in the period of 180
days before the initial diagnosis have been measured using
Elixhauser comorbidity groups.
As in model I, the effect of density of general practition-
ers (model IIa) and the effect of density of gastroenterol-
ogists (model IIb) on survival has been measured in two
separate estimations to account for multicollinearity.
2.4. Sensitivity analysis and statistical analysis
Several sensitivity analyses have been performed. Tests
were made for different kinds of specialty treatment
centers, e.g., treatment centers specialized in cancer or in
tumor resection. In addition, the threshold for the deﬁni-
tion of specialist treatment centers was varied between
the top 5% and top 20% of hospitals. As mentioned above,
alternative comorbidity indices were used within all mod-
els, i.e., the Charlson comorbidity index and a modiﬁed
Elixhauser comorbidity index [24]. In addition, a subgroup
analysis was performed to test model II using patients who
obtained surgery, excluding patients who obtained radio-
and chemotherapy only. Within this subgroup analysis
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the number of gastric surgeries performed in hospital was
included as an explanatory variable.
Efron approximation was  applied in both Cox propor-
tional hazard models to control for tied data [25]. To
account for correlation within postcode areas, the regres-
sion was  conducted with a sandwich variance estimate
[26]. Scaled Schoenfeld residuals were plotted against time
to assess whether the proportional hazard assumption
of the Cox proportional hazard models was met [27,28].
In addition, the logarithm of survival time was plotted
against the logarithm of the negative logarithm of the esti-
mated survivor function and checked for proportionality
[29]. Mantel–Haenszel chi2-tests were performed to test
whether the inﬂuence of covariates was signiﬁcantly dif-
ferent from zero. A p-value of <0.05 was considered as
statistically signiﬁcant and a p-value of <0.01 as highly
statistically signiﬁcant. All analyses were performed using
SAS/STAT 9.2.
3. Results
After reﬁnement of the dataset, a sample of 2175 gastric
cancer patients was  obtained to estimate delay in diag-
nosis (model I), while a sample of 1690 gastric cancer
patients was  obtained to estimate survival (model II). Sam-
ple characteristics are shown in Table 1 for both models.
The sample contains a majority of males (65%) and the aver-
age age is 65.12 years. Accordingly, age-related diseases
such as cardiac arrhythmias (13%), hypertension (47%), and
diabetes (21%) are very prevalent. Results of sensitivity
analyses showed no substantial differences to the results
presented.
The predictive survival curve was plotted for the estima-
tion of delay in diagnosis (Fig. 1). It can be observed that 34%
of patients are diagnosed immediately, but 16% of patients
show ﬁrst symptoms more than one year before diagnosis.
The results of the Cox regression on the estimation of delay
in diagnosis (model I) are presented in Table 2. As stated in
the hypothesis, it can be observed that increased density
of general practitioners in urban areas (p = 0.0262) and in
rural areas (p < 0.0001) has a signiﬁcant negative impact
on delay in diagnosis. This means that one more general
practitioner per 100 square kilometers in urban areas
300 400 500
 dia gnosis (day s)
iagnosis rate (model I).
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Table 1
Summary of sample characteristics (model I: estimation of delay in diagnosis; model II: estimation of survival).
Model I Model II
Number of observations 2175 1690
Percent censored 0.0% 57.4%
Variables Mean SD Mean SD
Dependent variables
Delay in diagnosis (days) 120.43 170.34
Survival (days) 254.97 237.46
Explanatory variables
Outpatient characteristics
Urban area
Density of general practitioners (per 100 km2) 93.87 68.75 92.71 67.47
Density of gastroenterologists (per 100 km2) 1.97 1.66 1.85 1.55
Population density (per km2) 1424.99 989.67 1433.52 995.37
Rural  area
Density of general practitioners (per 100 km2) 13.96 14.97 13.98 16.35
Density of gastroenterologists (per 100 km2) 0.21 0.32 0.19 0.32
Population density (per km2) 200.53 114.63 200.08 113.93
Inpatient characteristics
Distance to specialty treatment center (km) 23.30 24.80
Number of gastric cancer cases 84.59 106.50
Intensity of nursing care 0.78 0.25
Delay  in diagnosis (days) 118.12 167.94
Variables of control
Sex (female = 1) 34.8% 31.9%
Patient’s propensity to visit a physician 5.14 3.35
Age  in categories
Age < 60 years 30.4% 28.3%
60  ≤ age < 70 years 30.3% 31.1%
70  ≤ age < 80 years 27.8% 28.8%
Age  ≥ 80 years 11.5% 11.8%
Treatment
Gastric surgery 67.3%
Gastric surgery (days after diagnosis) 50.40 58.59
Radiotherapy 5.9%
Radiotherapy (days after diagnosis) 188.31 200.25
Chemotherapy 42.4%
Chemotherapy (days after diagnosis) 106.83 140.42
Comorbiditiesa
Congestive heart failure 7.3% 8.3%
Cardiac arrhythmias 13.5% 15.3%
Valvular disease 5.3% 6.3%
Pulmonary circulation disorders 1.2% 1.8%
Peripheral vascular disorders 8.8% 10.2%
Hypertension uncomplicated 41.8% 47.1%
Hypertension complicated 5.4% 6.4%
Paralysis 1.5% 1.6%
Other neurological disorders 3.5% 3.4%
Chronic pulmonary disease 14.9% 16.1%
Diabetes uncomplicated 15.3% 18.0%
Diabetes complicated 6.3% 7.3%
Hypothyroidism 5.2% 6.0%
Renal failure 4.0% 4.7%
Liver disease 8.3% 11.9%
Peptic ulcer disease excluding bleeding 0.2% 8.1%
AIDS/HIV 0.0% 0.1%
Lymphoma 1.4% 2.2%
Metastatic cancer 3.3% 8.0%
Solid tumor without metastasis 12.0% 12.8%
Rheumatoid arthritis/collagenvascular diseases 4.6% 5.1%
Coagulopathy 2.8% 3.7%
Obesity 8.1% 9.1%
Weight loss 0.4% 3.8%
Fluid and electrolyte disorders 2.5% 3.8%
Blood loss anemia 0.3% 0.8%
Deﬁciency anemias 3.4% 5.9%
Alcohol abuse 2.2% 2.3%
Drug abuse 0.2% 0.2%
Psychoses 1.1% 1.0%
Depression 9.5% 11.6%
a Comorbidities measured within 180 days before ﬁrst symptom (model I), comorbidities measured within 180 days before diagnosis (model II).
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Table 2
Results of Cox proportional hazard regression analysis of delay in diagnosis of 2175 gastric cancer patients.
Independent variables Model Ia (n = 2175) Model Ib (n = 2175)
Diagnosis
hazard ratio
-Estimate p-Value Diagnosis
hazard ratio
-Estimate p-Value
Variables of interest
Outpatient characteristics
Urban area
Density of general practitioners (per 100 km2) 1.0008 0.0008 0.0262
Density of gastroenterologists (per 100km2) 1.0167 0.0166 0.2480
Rural  area
Density of general practitioners (per 100 km2) 1.0085 0.0085 <0.0001
Density of gastroenterologists (per 100 km2) 1.4810 0.3927 <0.0001
Inpatient characteristics
Distance to specialist treatment center (km) 1.0005 0.0005 0.4395 1.0004 0.0004 0.5353
Variables of control
Sex (female = 1) 1.1369 0.1283 0.1610 1.1308 0.1229 0.1775
Sex  × time (if sex = female and delay in
diagnosis < 270 days)
0.6796 −0.3862 0.0002 0.6849 −0.3785 0.0003
Patient’s propensity to visit a physician 1.0081 0.0080 0.2919 1.0077 0.0077 0.3128
Age  in categories
Age < 60 years (%) 0.9788 −0.0214 0.7842 0.9825 −0.0176 0.8222
60  ≤ age < 70 years (%) 1.0599 0.0582 0.4281 1.0613 0.0595 0.4205
0.126
Refere70  ≤ age < 80 years (%) 1.1352 
Age  ≥ 80 years
Elixhauser comorbiditygroups included (not shown)
increases the chance of getting diagnosed by 0.08%, while
one more general practitioner per 100 square kilometers
increases the chance of getting diagnosed by 0.85% in rural
areas. Higher density of gastroenterologists is not observed
to have a signiﬁcant impact in urban areas (p = 0.2480); it
does, however, have a highly signiﬁcant impact in rural
areas (p < 0.0001): in rural areas one more gastroenterol-
ogist per 100 square kilometers increases the chance of
getting diagnosed by 48%. Distance to a specialty treatment
center has no effect on delay in diagnosis (p = 0.4395).
The overall chance of getting diagnosed does not dif-
fer between females and males; however, the chance of
getting diagnosed for females is 47.13% (p = 0.0002) lower
than for males within the ﬁrst 270 days. Signiﬁcant dif-
ferences between age categories and between patients
with different propensities to visit a physician could not
be demonstrated. The existence of another primary can-
cer site increases the chance of diagnosis by 38.35% (p =
0.0286).
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Fig. 2 shows the predictive survival curve for patients
diagnosed with gastric cancer. According to the sam-
ple, 35% of the population dies within one year. The
results of the Cox proportional hazard model are shown
in Table 3. There was no effect of outpatient healthcare
infrastructure on survival. Regarding inpatient healthcare
infrastructure, a highly signiﬁcant impact of the number
of gastric cancer cases on survival could be observed. Hos-
pitals with 100 extra gastric cancer cases reduced the risk
of death by 17.23% (p < 0.0001). However, intensity of nurs-
ing care (p = 0.0875), delay in diagnosis (p = 0.7891), and sex
(p = 0.1298) has no impact on survival.
As expected, there is a highly signiﬁcant higher survival
rate for all age groups (p < 0.0001) younger than 80 years
as compared to the reference group (age > 80). Patients
who obtained gastric surgery show a similar survival rate
(p = 0.1819) to patients who  did not. A highly signiﬁcant
decrease in survival rates for patients who obtained radio-
or chemotherapy is observed.
12001000800600
vival (days)
urvival rate (model II).
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Table 3
Results of Cox proportional hazard regression analysis of 1690 inpatient gastric cancer patients.
Independent variables Model IIa (n = 1690) Model IIb (n = 1690)
Hazard ratio -Estimate p-Value Hazard ratio -Estimate p-Value
Variables of interest
Outpatient characteristics
Urban area
Density of general practitioners (per 100 km2) 0.9996 −0.0004 0.5384
Density of gastroenterologists (per 100 km2) 0.9751 −0.0252 0.3644
Rural  area
Density of general practitioners (per 100 km2) 1.0008 0.0008 0.8268
Density of gastroenterologists (per 100 km2) 0.9024 −0.1027 0.6294
Inpatient characteristics
Number of gastric cancer cases 0.9983 −0.0017 <0.0001 0.9983 −0.0017 <0.0001
Intensity of nursing care 0.7690 −0.2627 0.0875 0.7839 −0.2434 0.1080
Delay  in diagnosis 0.9999 −0.0001 0.7891 0.9999 −0.0001 0.7563
Variables of control
Treatment characteristics
Gastric surgery × time 0.8848 −0.1224 0.1819 0.8859 −0.1211 0.1855
Radiotherapy × time 1.7458 0.5572 0.0034 1.7428 0.5555 0.0034
Chemotherapy × time 2.7722 1.0196 <0.0001 2.7713 1.0193 <0.0001
Sex  (female = 1) 0.8689 −0.1405 0.1298 0.8722 −0.1368 0.1407
Age  in categories
Age < 60 years (%) 0.3063 −1.1833 <0.0001 0.3063 −1.1833 <0.0001
60  ≤ age < 70 years (%) 0.3455 −1.0628 <0.0001 0.3470 −1.0585 <0.0001
−0.7494
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. Discussion
This study is the ﬁrst to evaluate the impact of health-
are infrastructure on delay in diagnosis, and the impact
f healthcare infrastructure and delay in diagnosis on
urvival of a rare disease, using a large sample of com-
rehensive administrative data. Strength of this study is
he measurement of out- and inpatient healthcare infras-
ructure in several dimensions, i.e., urban and rural areas,
ifferent specialties of physicians, distances to specialty
reatment centers, and hospital characteristics before and
fter diagnosis of gastric cancer. In addition the models
omprehensively control for comorbidities and demo-
raphic aspects.
A higher density of physicians reduces delay in diag-
osis. However, the effect is stronger in rural areas than in
rban areas – one more gastroenterologist in an urban area
ffectively has no impact on delay in diagnosis. This implies
hat outpatient healthcare infrastructure regarding gas-
roenterologists is sufﬁcient in urban areas, whereas there
s still room for improvement in rural areas. This ﬁnding
s also in concordance with ongoing political discussions
n Germany about overprovision of physicians in urban
reas and under provision in rural areas [30]. However,
lthough a higher than optimal number of physicians may
ead to supplier-induced-demand and inefﬁcient overuti-
ization of health resources, empirical evidence in literature
n this relationship is sparse [10].
The effect of gastroenterologists may  be considered as
igh compared to the impact of general practitioners. How-
ver, if all results for outpatient healthcare infrastructure
re compared using relative ﬁgures, similar results are
btained for all physician specialties. An increase of 10%
n the number of both general practitioners and gastroen-
erologists results in an increase of the chance of getting <0.0001 0.4741 −0.7463 <0.0001
ce Reference
diagnosed of 0.72% (p = 0.0262) for general practitioners
in urban areas, 1.19% (p < 0.0001) for general practitioners
in rural areas, no signiﬁcant effect for gastroenterologists
in urban areas (p = 0.2480), and 0.99% (p < 0.0001) for gas-
troenterologists in rural areas. Similar to the interpretation
of the effect between general practitioners and gastroen-
terologists, the different level of effect between urban and
rural areas should be interpreted with care because pop-
ulation density is lower in rural areas. In relative terms,
an increase of 10% in the number of general practitioners
results in an increase of the chance of getting diagnosed of
0.72% (p = 0.0262) in urban areas and 1.18% (p < 0.0001) in
rural areas.
Inpatient healthcare infrastructure (distance to spe-
cialty treatment center) did not impact delay in diagnosis.
One might ﬁnd this ﬁnding expectable because most of
the patients are initially diagnosed in the outpatient sector
and thereupon referred to hospital. However, one might
also expect that there is an increased knowledge-transfer
between specialty treatment centers and surrounding out-
patient healthcare infrastructure. In his review, Agrawal
cites several studies which evaluated the effect of geo-
graphic distance between university and industry locations
on university-to-industry knowledge-transfer. Agrawal
concludes that commercialization of university know-how
remains localized to the region of invention [31]. The
result of model I indicates that there is no increased
knowledge-transfer between specialty treatment centers
in the geographic area of a specialty treatment center.
However, Agrawal’s results seem not to be extensible to
geographic knowledge spillovers between German out-
and inpatient healthcare structures, especially because the
reviewed studies refer to the U.S., where distances are usu-
ally larger than in Germany. However, the effect observed
need not be interpreted as a lack of knowledge-transfer, but
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rather as indicating that knowledge is already being shared
between sectors irrespective of geography.
Diagnosis for females is signiﬁcantly lower during the
ﬁrst 270 days than for males. This may  result from lower
prevalence of gastric cancer in females. The attending
physician might ﬁrst suspect that another disease is caus-
ing the early gastric cancer symptoms.
Propensity to visit a physician does not show any
impact on delay in diagnosis. Essentially, there may  be two
underlying factors with contrary effects that could not be
differentiated or controlled for. First, continuity in medical
care and therefore a high propensity to visit a physician has
been found to have a positive impact on outcomes [32];
however, physicians tend to neglect non-speciﬁc symp-
toms, such as early gastric cancer symptoms, of patients
who have a high propensity to visit a physician.
In model II no impact of outpatient healthcare infras-
tructure on survival could be observed. This is intuitively
obvious, since a serious and life-threatening disease has
been diagnosed. Lack of outpatient healthcare infrastruc-
ture, as seen in the ﬁrst model, is not relevant, because both
patient and physician highly prioritize treatment of the dis-
ease. Due to the seriousness of the disease, the patient will
visit the physician regardless of distance and the physi-
cian will provide the patient with appropriate treatment.
In their study on waiting times in the German outpatient
sector, Roll et al. ﬁnd that patients with a more severe
condition obtain faster access to healthcare [33], which is
concordant with the present ﬁndings.
A highly signiﬁcant relationship can be observed
between the number of gastric cancer cases performed by
specialty treatment centers and survival. The more gastric
cancer cases are performed at the hospital, the better is the
outcome. This ﬁnding can be explained by learning effects
on the hospital as an organization. A positive relationship
between surgeon volume and specialization on outcomes
has been shown by a number of studies, but evidence on
the effect of high hospital volume and specialization on out-
comes for surgical indications is limited [11,12]. However,
the effect of surgical volumes was addressed in the sensitiv-
ity analyses, and results remained robust after controlling
for surgeon volumes instead of gastric cancer cases – i.e., a
highly signiﬁcant and positive relationship between hospi-
tal surgical volumes and survival of gastric cancer patients
could be observed.
Analysis of inpatient healthcare infrastructure shows no
impact of intensity of nursing care on survival. Intensity of
nursing care is measured at hospital level, but this does not
necessarily represent the intensity of nursing care provided
to gastric cancer patients. Similar to the ﬁndings regarding
outpatient healthcare infrastructure, care may  be priori-
tized for gastric cancer patients and therefore there may
be no care capacity constraints for this group.
Delay in diagnosis showed no impact on survival. An
explanation for this surprising result is that patients with
symptoms which alarm the patient and the physician are
generally affected by a more aggressive type of gastric can-
cer, whereas patients with non-alarming symptoms may
be affected by a less aggressive and slower-progressing
cancer. Maconi et al. ﬁnd similar results in their review
of fourteen studies, concluding that duration of symptoms05 (2012) 128– 137 135
is not related to poor outcomes and that delay in diag-
nosis cannot be regarded as a relevant prognostic factor
for survival [34]. However, it cannot be completely ruled
out that reduced delay in diagnosis has a positive impact
on survival. Several studies show that improved screening
– which leads to a reduction in delay – results in better
outcomes [35–38].
The counterintuitive effect of radio- and chemotherapy
results from a bias. Patients with a more advanced gastric
cancer are more likely to obtain radio- or chemotherapy.
However, as these variables are used as a control, this bias
has no effect on the overall ﬁndings.
Elixhauser comorbidity groups were used to control for
comorbidities. This measure has demonstrated superior
performance compared to other indices in several stud-
ies [39–41].  Although the Charlson comorbidity index [42]
is also widely used in the literature, this index seems not
to be a valid prognostic indicator for gastric cancer [43].
However, the Charlson comorbidity index was  tested in the
sensitivity analyses. Again, the results remained robust.
5. Limitations
The study is based on administrative data. Administra-
tive data has the advantage of providing a holistic overview
of an entire population covering all out- and inpatient care
[44] but is, however, data which is collected for reim-
bursement purposes. Therefore administrative data partly
lacks important clinical data – e.g., regarding tumor stage
– that seems to be a strong predictor of prognosis [19]. The
absence of clinical data may  also lead to a selection bias in
the model measuring survival. One may  assume that spe-
cialty treatment centers receive primarily patients in early
stages of the disease with high chances of healing, while
patients in later stages, where only palliative treatment
options are available, are treated at local non-specialized
hospitals. However, comorbidities that represent general
health status have been included in the model and comor-
bidities are used as a proxy for severity of the disease.
Another drawback from administrative data may  result
from the limited time under observation before initial diag-
nosis of gastric cancer. For example, patients that had
cancer in the past are screened on a regular basis and this
could bias results. Again, controlling for comorbidities min-
imizes this bias, but it cannot be eliminated.
A further limitation might be the use of administrative
data from only one sickness fund. For historical reasons,
the populations of sickness funds in Germany vary accord-
ing to several characteristics. However, although historical
reasons may  well give reason to assume that the popu-
lation of Techniker Krankenkasse has a higher education
than on average, it is very unlikely that patients are treated
differently in hospital. In addition, the differences in pop-
ulation do not have an impact on the ﬁrst analysis of delay
in diagnosis. Results may  therefore be generalized across
the German population.
Measurement of delay in diagnosis is measured from the
ﬁrst symptom that is documented by a physician until ini-
tial diagnosis: therefore the model in fact measured delay
caused by the physician, but data was  not available to
measure delay caused by patients, e.g., delay through late
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ontacting of the physician for an appointment. Thus, delay
n diagnosis may  be underestimated. Non-recognition of
ymptoms, socioeconomic status, comorbidities, and ﬁrst
resenting to hospital seem to be valid predictors of delay
aused by patients [8].  However, this study controls for
omorbidities, and ﬁrst presenting to hospital seems not
o be relevant for cancer in a German context, because
atients usually have to be referred to a hospital by a physi-
ian.
Onset of the disease was determined using gastric-
ancer-related symptoms and some of these symptoms
ight be non-speciﬁc for gastric cancer. From an ex-post-
iew – as it is used in this study – these symptoms often
eveal as early signs of gastric cancer although there might
ave been other reasons for the occurrence of these symp-
oms. However, the chosen set of symptoms was based on
n extensive literature review and all of the symptoms have
een double checked with experts.
There is a steady stream of literature which shows that
ge, years in practice, and experience of the physician
nﬂuences outcomes [45]; however, in this study health-
are infrastructure is measured by full-time equivalents
f physicians, and the identity of the attending physician
annot be determined due to data privacy protection. The
ain interest of this study, though, was not to evaluate the
uality of physicians, but to evaluate available healthcare
nfrastructure.
. Conclusion
The objective of this study was to evaluate whether
ealthcare infrastructure impacts delay in diagnosis and
hether healthcare infrastructure and delay in diagnosis
mpacts survival in cases of gastric cancer. According to the
ata analyzed, there is evidence that healthcare infrastruc-
ure has an impact on delay in diagnosis and survival in
ases of gastric cancer. Delay in diagnosis can be reduced
y higher availability of general practitioners and gastroen-
erologists in rural areas. However, in urban areas a higher
ensity of general practitioners leads to a lower delay in
iagnosis, whereas there is no impact of additional gas-
roenterologists on delay in diagnosis.
Once a diagnosis of such a serious and rare disease
as been made, patients seem to be treated with priority,
nd availability constraints of out- and inpatient health-
are infrastructure may  therefore not apply. An increase
n general practitioners, gastroenterologists, or intensity of
ursing care would therefore not result in better survival
or gastric cancer patients.
In Germany, legislation enforces minimum hospital vol-
mes and minimum surgeon volumes for several health
nterventions, to ensure a high quality of treatment. Ongo-
ng discussions show that it is difﬁcult to determine the
hreshold to be deﬁned for minimum volumes, especially
ecause there is often a lack of evidence from national
tudies and there is a trade-off between local treatment
ptions for patients and the degree of hospital special-
zation [46,47]. However, this study shows that learning
ffects occur with increased hospital volumes and there-
ore suggests that it might be favorable to centralize
[
[05 (2012) 128– 137
inpatient treatment of gastric cancer to improve survival
of gastric cancer patients.
Acknowledgements
This study was  supported by a research grant from the
Federal Ministry for Research and Education (BMBF) in
Germany (grant number: BMBF 01FG09007). The sponsor
had no role in the study design, collection and analysis of
data, the writing of the report, or the submission of the
paper for publication.
I would like to express my  gratitude to Tom Stargardt
and Jonas Schreyögg who provided very valuable guidance.
I am also indebted to Katharina Fischer for her helpful
comments. Finally, I want to thank the two anonymous
reviewers for their invaluable comments and excellent sug-
gestions.
References
[1] Orphanet prevalence of rare diseases: bibliographic data. Orphanet
Report Series: Orphanet; 2009.
[2] Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric
cancer. Lancet 2009;374:477–90.
[3] Robert Koch-Institut. Krebs in Deutschland 2005/2006. Berlin: Häu-
ﬁgkeiten und Trends; 2010.
[4] International Agency for Research on Cancer. WHO  cancer mortality
database. World Health Organization; 2011.
[5] Beers MH,  Albert RK. Merck research laboratories. The Merck manual
of  diagnosis and therapy. Whitehouse Station, NJ: Merck Research
Laboratories; 2006.
[6] Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diag-
nosis of oesophagogastric cancer: a consecutive case series. BMJ
1997;314:467–70.
[7] Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cut-
sem E. Gastric cancer. Critical Reviews in Oncology Hematology
2009;71:127–64.
[8] Macdonald S, Macleod U, Campbell NC, Weller D, Mitchell E. System-
atic review of factors inﬂuencing patient and practitioner delay in
diagnosis of upper gastrointestinal cancer. British Journal of Cancer
2006;94:1272–80.
[9] Shankar SM,  Arbogast PG, Mitchel E, Ding H, Wang WC,  Grifﬁn MR.
Impact of proximity to comprehensive sickle cell center on utiliza-
tion of healthcare services among children with sickle cell disease.
Pediatric Blood & Cancer 2008;50:66–71.
10] Léonard C, Stordeur S, Roberfroid D. Association between physician
density and health care consumption: a systematic review of the
evidence. Health Policy 2009;91:121–34.
11] Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Mac-
donald JS, et al. Impact of hospital volume on recurrence and survival
after surgery for gastric cancer. Annals of Surgery 2007;245:426–34.
12] Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late
survival after cancer surgery. Annals of Surgery 2007;245:777–83.
13] Nomura E, Tsukuma H, Ajiki W,  Oshima A. Population-based study
of  relationship between hospital surgical volume and 5-year sur-
vival of stomach cancer patients in Osaka, Japan. Cancer Science
2003;94:998–1002.
14] Stargardt T, Schreyögg J. A framework to evaluate the effects of
small area variations in healthcare infrastructure on diagnostics and
patient outcomes of rare diseases based on administrative data.
Health Policy 2012.
15] Deutschland. Statistisches Bundesamt. Gemeindeverzeichnis – Gebi-
etsstand: 31.12.2008. Wiesbaden: Statistisches Bundesamt; 2008.
16] Google maps. Directions by car – suggested routes; 2011.
17] Gemeinsamer Bundesausschuss. Qualitätsbericht der Kranken-
häuser. Berlin; 2008.
18] Kahrilas PJ. Gastroesophageal reﬂux disease. JAMA: The Journal of
the American Medical Association 1996;276:983–8.
19] Wanebo HJ, Kennedy BJ, Chmiel J, Steele Jr G, Winchester D, Osteen R.
Cancer of the stomach. A patient care study by the American College
of Surgeons. Annals of Surgery 1993;218:583–92.
20] Swynnerton BF, Truelove SC. Carcinoma of the stomach. British Med-
ical Journal 1952;1:287–92.
 Policy 1
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[C.R. Blankart / Health
21]  Elixhauser A, Steiner C, Harris DR, Coffey RM.  Comorbidity measures
for use with administrative data. Medical Care 1998;36:8–27.
22] Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al.
Coding algorithms for deﬁning comorbidities in ICD-9-CM and ICD-
10 administrative data. Medical Care 2005;43:1130–9.
23] Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of
Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 admin-
istrative databases. BMC Health Service Research 2008;8:12.
24] van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A
modiﬁcation of the elixhauser comorbidity measures into a point
system for hospital death using administrative data. Medical Care
2009;47:626–33, 10.1097/MLR.0b013e31819432e5.
25] Efron B. The efﬁciency of Cox’s likelihood function for censored data.
Journal of the American Statistical Association 1977;72:557–65.
26] Lin DY, Wei  LJ. The robust inference for the Cox proportional
hazards model. Journal of the American Statistical Association
1989;84:1074–8.
27] Grambsch PM, Therneau TM.  Proportional hazards tests and diag-
nostics based on weighted residuals. Biometrika 1994;81:515–26.
28] Schoenfeld D. Partial residuals for the proportional hazards
regression-model. Biometrika 1982;69:239–41.
29] Allison PD. Survival analysis using SAS®: a practical guide. Cary, NC:
SAS Press; 2008.
30] Federal Ministry of Health. Entwurf eines Gesetzes zur
Verbesserung der Versorgungsstrukturen in der gesetzlichen
Krankenversicherung. Berlin; 2011.
31] Agrawal A. University-to-industry knowledge transfer: literature
review and unanswered questions. International Journal of Manage-
ment Reviews 2001;3:285–302.
32] van Walraven C, Oake N, Jennings A, Forster AJ. The association
between continuity of care and outcomes: a systematic and critical
review. Journal of Evaluation in Clinical Practice 2010;16:947–56.
33] Roll K, Stargardt T, Schreyögg J. Effect of type of insurance and
income on waiting time for outpatient care. HCHE Research Papers
2011;03:1–37.34] Maconi G, Manes G, Porro GB. Role of symptoms in diagnosis
and outcome of gastric cancer. World Journal of Gastroenterology
2008;14:1149–55.
35] Blackshaw GR, Barry JD, Edwards P, Allison MC,  Lewis WG.
Open-access gastroscopy is associated with improved outcomes in
[
[05 (2012) 128– 137 137
gastric cancer. European Journal of Gastroenterology & Hepatology
2003;15:1333–7.
36] Miyamoto A, Kuriyama S, Nishino Y, Tsubono Y, Nakaya N, Ohmori K,
et  al. Lower risk of death from gastric cancer among participants of
gastric cancer screening in Japan: a population-based cohort study.
Preventive Medicine 2007;44:12–9.
37] Fukao A, Tsubono Y, Tsuji ISHI, Sugahara N, Takano A. The evalu-
ation of screening for gastric cancer in Miyagi Prefecture, Japan: a
population-based case-control study. International Journal of Cancer
1995;60:45–8.
38] Hisamichi S. Screening for gastric cancer. World Journal of Surgery
1989;13:31–7.
39] Chu YT, Ng YY, Wu SC. Comparison of different comorbidity measures
for use with administrative data in predicting short- and long-term
mortality. BMC  Health Services Research 2010;10:140.
40] Southern DA, Quan H, Ghali WA.  Comparison of the Elixhauser and
Charlson/Deyo methods of comorbidity measurement in administra-
tive data. Medical Care 2004;42:355–60.
41] Lieffers JR, Baracos VE, Winget M,  Fassbender K. A comparison of
charlson and elixhauser comorbidity measures to predict colorectal
cancer survival using administrative health data. Cancer 2010.
42] Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of clas-
sifying prognostic comorbidity in longitudinal studies: development
and validation. Journal of Chronic Diseases 1987;40:373–83.
43] Lubke T, Monig SP, Schneider PM, Holscher AH, Bollschweiler E.
Does Charlson-comorbidity index correlate with short-term out-
come in patients with gastric cancer. Zentralblatt fur Chirurgie
2003;128:970–6.
44] Schubert I, Koster I, Kupper-Nybelen J, Ihle P. Health services research
based on routine data generated by the SHI. Potential uses of health
insurance fund data in health services research. Bundesgesund-
heitsblatt Gesundheitsforschung Gesundheitsschutz 2008;51:1095–
105.
45] Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: the
relationship between clinical experience and quality of health care.
Annals of Internal Medicine 2005;142:260–73.
46] Town RJ, Heslin MJ. Regionalization versus competition in complex
cancer surgery. Health Economics, Policy and Law 2007;2:51–71.
47] Blum K, Offermanns M.  Umverteilungswirkungen der Mindestmen-
genregelung. Das Krankenhaus 2004:787–90.
